Stranius75 wrote: MMCap has participated in most Canopy financings since 2014, Linton said. But its name does not appear to surface in Canopy’s public documents, suggesting the fund’s total impact could be much larger than $600 million.
“Those funds, for the most part, make up anywhere from 50 to 90 per cent of any deal. And early on they were like 90 to 100 per cent of those deals, the same five or six funds popping up on every single list,” said one industry insider, who spoke on condition of anonymity. Numerous other industry insiders echoed this assessment.
The deal, the third involving BMO in the past six months, appeared to confirm a narrative developing in Canada’s cannabis industry: that mainstream financial support, for the most part sidelined by legal and reputational concerns, was finally pouring into the sector.
“The retail investor likely would be concerned if they understood how it worked on the inside of the tent,” said Paul Rosen, former chief executive of PharmaCan Capital Corp., which became Cronos Group Inc., and a prominent investor in the space. “Retail investors tend to pay for the party that the insiders are enjoying.”
It’s the history of all bubbles and crashes: it's always that retail guy getting in at the end, and they're buying the worst companies
investment manager
https://www.google.ca/amp/business.financialpost.com/cannabis/how-a-handful-of-hedge-funds-cornered-cannabis-financing-and-made-a-killing-in-the-process/amp